mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.3 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.042 |
0.3 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.3 |
mRNA |
fulvestrant |
CTRPv2 |
pan-cancer |
AAC |
0.091 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.3 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.3 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.038 |
0.3 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.036 |
0.3 |